ArticleFrontiers in pediatrics2025
A single blood luteinizing hormone level of triptorelin stimulation test can diagnose hypothalamic-pituitary-gonadal axis activation in girls with high body mass index.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Syndrome differentiation and treatment of pediatric central precocious puberty: role of the spleen-kidney axis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Body mass index (BMI) may influence peak luteinizing hormone (PLH) levels during gonadotropin releasing hormone (GnRH) or GnRH analogues stimulation testing. BMI effects should be considered when interpreting test results for pubertal disorders in girls with overweight/obesity, but few studies have excluded it. Methods: This was a hospital data-based retrospective study. Girls with puberty disorders who had been followed up for six months to two years were enrolled in the study. They were divided into the overweight/obesity group and the normal BMI group and all underwent triptorelin stimulation test. Blood samples were collected at 0 min before and 20, 40, and 60 min after the test. Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) serum concentrations were quantified by immunochemiluminometric assay. Results: A total of 422 girls who underwent 454 triptorelin stimulation tests were included in this study. Among 148 tests performed on 142 overweight/obesity girls, 110 tests were hypothalamic-pituitary-gonadal axis (HPGA) activated and 38 tests were HPGA non-activated. Among 306 tests performed on 284 girls with normal BMI, 214 tests were HPGA activated and 92 tests were non-activated. LH, FSH, and estradiol levels in girls whose HPGA activated were significantly higher than those non-activated. The area under the curves of LH20 min, LH40 min, LH60 min and PLH after triptorelin stimulation tests in girls with overweight/obesity for diagnosing HPGA activation were 0.996, 0.980, 0.990 and 0.994, respectively. There was no statistical significance in the area under the curves between LH20 min, LH40 min, LH60 min and PLH. When LH20 min, LH40 min, LH60 min and PLH were ≥3.26 IU/L, ≥4.09 IU/L, ≥4.27 IU/L and ≥4.51 IU/L, the sensitivity for diagnosing HPGA activation in girls with overweight/obesity were 99.03%, 95.45%, 98.18% and 97.27%, and the corresponding specificity were 94.59%, 97.37%, 100.00%, and 100.00%, respectively. The cut-off value of serum LH60 min after the triptorelin stimulation test for diagnosing HPGA activation in precocious pubertal girls with overweight/obesity was 4.45 IU/L, and in pubertal girls with overweight/obesity was 4.20 IU/L. Conclusions: LH measurements obtained at 20, 40, or 60 min post-triptorelin stimulation can diagnose HPGA activation in girls with high BMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.